Results 11 to 20 of about 149,070 (296)
Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis
In humans, germline TP53 mutations predispose carriers to a wide spectrum of cancers, which is known as Li–Fraumeni syndrome (LFS). To date, the association of melanomas with LFS remains unestablished.
Rensen Ran +9 more
doaj +1 more source
Objective: Limited data about the prognostic significance of BCL2 mutations and BCL2 copy number variations in diffuse large B-cell lymphoma (DLBCL) are available.
Yan Qin +11 more
doaj +1 more source
Methylation of p53-responsive oncosuppressive microRNA genes in hemoblastosis
The purpose of the study was to present up-to-date data on the frequency and significance of a number of p53-responsive oncosuppressive micrornas genes methylation in malignant neoplasms of the blood system.Material and methods.
E. N. Voropaeva +5 more
doaj +1 more source
The TP53 fertility network [PDF]
The TP53 gene, first described in 1979, was identified as a tumor suppressor gene in 1989, when it became clear that its product, the p53 nuclear phosphoprotein, was frequently inactivated in many different forms of cancers. Nicknamed "guardian of the genome", TP53 occupies a central node in stress response networks.
Paskulin, Diego d'Avila +4 more
openaire +7 more sources
Introduction: Serum α-fetoprotein (AFP), Lens culinaris agglutinin-reactive AFP (AFP-L3), and des-γ-carboxyprothrombin (DCP) are useful biomarkers of hepatocellular carcinoma (HCC).
Keun Soo Ahn +11 more
doaj +1 more source
Identified as a TP53-binding protein, 53BP1 is a key regulator of the cellular response to double-strand breaks, a TP53-independent activity. Recent data have established a new TP53-dependent function for 53BP1 in mitotic surveillance after centrosome loss.
Soussi, Thierry, Kroemer, Guido
openaire +2 more sources
Glioblastoma is a solid, infiltrating, and the most frequent highly malignant primary brain tumor. Our aim was to find the correlation between sex, age, preoperative Karnofsky performance status (KPS), presenting with seizures, and extent of resection ...
Maurizio Salvati +12 more
doaj +1 more source
CDK4/6 inhibition in cancer: the cell cycle splicing connection
Cyclin-dependent kinase −4 and −6 (CDK4/6) inhibitors are currently being assessed in clinical trials for the treatment of many cancers including melanoma.
Karen E. Sheppard, Shatha AbuHammad
doaj +1 more source
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis [PDF]
A novel resource centre for TP53 mutations and mutants has been developed (http://p53.fr). TP53 gene dysfunction can be found in the majority of human cancer types. The potential use of TP53 mutation as a biomarker for clinical studies or exposome analysis has led to the publication of thousands of reports describing the TP53 gene status in >10,000 ...
Leroy, Bernard +6 more
openaire +3 more sources
Ovarian cancer represents the fourth most frequent type of cancer among females and is the leading cause of death from gynecological cancer in the western world. This review describes gene alterations in ovarian cancer. Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ...
Monique, Schuijer, Els M J J, Berns
openaire +2 more sources

